Trevor Tivey - Publications

Affiliations: 
2019 Oregon State University, Corvallis, OR 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tivey TR, Parkinson JE, Weis VM. Host and Symbiont Cell Cycle Coordination Is Mediated by Symbiotic State, Nutrition, and Partner Identity in a Model Cnidarian-Dinoflagellate Symbiosis. Mbio. 11. PMID 32156819 DOI: 10.1128/Mbio.02626-19  0.535
2020 Tivey TR, Parkinson JE, Mandelare PE, Adpressa DA, Peng W, Dong X, Mechref Y, Weis VM, Loesgen S. N-Linked Surface Glycan Biosynthesis, Composition, Inhibition, and Function in Cnidarian-Dinoflagellate Symbiosis. Microbial Ecology. PMID 31982929 DOI: 10.1007/S00248-020-01487-9  0.523
2018 Layer JV, Cleary JP, Brown AJ, Stevenson KE, Morrow SN, Van Scoyk A, Blasco RB, Karaca E, Meng FL, Frock RL, Tivey T, Kim S, Fuchs H, Chiarle R, Alt FW, et al. Parp3 promotes long-range end joining in murine cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 30213852 DOI: 10.1073/Pnas.1801591115  0.412
2018 Parkinson JE, Tivey TR, Mandelare PE, Adpressa DA, Loesgen S, Weis VM. Subtle Differences in Symbiont Cell Surface Glycan Profiles Do Not Explain Species-Specific Colonization Rates in a Model Cnidarian-Algal Symbiosis. Frontiers in Microbiology. 9: 842. PMID 29765363 DOI: 10.3389/Fmicb.2018.00842  0.533
2017 Day TA, Layer JV, Cleary JP, Guha S, Stevenson KE, Tivey T, Kim S, Schinzel AC, Izzo F, Doench J, Root DE, Hahn WC, Price BD, Weinstock DM. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. Nature Communications. 8: 15110. PMID 28447610 DOI: 10.1038/Ncomms15110  0.311
2016 Jacobson C, Kopp N, Layer JV, Redd RA, Tschuri S, Haebe S, van Bodegom D, Bird L, Christie AL, Christodoulou A, Saur A, Tivey T, Zapf S, Bararia D, Zimber-Strobl U, et al. HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood. PMID 27742706 DOI: 10.1182/Blood-2016-04-711176  0.361
2015 Wu SC, Li LS, Kopp N, Montero J, Chapuy B, Yoda A, Christie AL, Liu H, Christodoulou A, van Bodegom D, van der Zwet J, Layer JV, Tivey T, Lane AA, Ryan JA, et al. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 28: 29-41. PMID 26175414 DOI: 10.1016/J.Ccell.2015.06.005  0.393
2015 Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, et al. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nature Medicine. 21: 71-5. PMID 25485910 DOI: 10.1038/Nm.3751  0.345
2014 Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend EC, van Bodegom D, Day TA, Wu SC, Liu H, Yoda A, Alexe G, Schinzel AC, Sullivan TJ, Malinge S, et al. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nature Genetics. 46: 618-23. PMID 24747640 DOI: 10.1038/Ng.2949  0.409
2014 Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, et al. GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition Blood. 124: 3567-3567. DOI: 10.1182/Blood.V124.21.3567.3567  0.436
2014 Kopp N, Tschuri S, Haebe S, Bodegom Dv, Bird L, Christie AL, Saur A, Christodoulou AN, Tivey T, Kung AL, Weigert O, Weinstock D. Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo Blood. 124: 1686-1686. DOI: 10.1182/Blood.V124.21.1686.1686  0.385
2014 Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend E, Bodegom Dv, Day TA, Wu S, Liu H, Yoda A, Alexe G, Schinzel A, Sullivan TJ, Malinge S, et al. Abstract 433: Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 Cancer Research. 74: 433-433. DOI: 10.1158/1538-7445.Am2014-433  0.424
2013 Yoda A, Adelmant G, Shindoh N, Chapuy B, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Tyner JW, Gotlib J, Deininger MW, Turley S, et al. The Beta-Subunit Of Heterotrimeric G Proteins Harbors Gain-Of-Function Mutations In Multiple Hematologic Malignancies Blood. 122: 2510-2510. DOI: 10.1182/Blood.V122.21.2510.2510  0.454
2013 Yoda A, Adelmant G, Shindoh N, Chapuy B, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Tyner JW, Gotlib J, Deininger MW, Turley S, et al. Abstract PR07: Novel oncogenic mutations in the beta subunit of heteromeric G-proteins identified by functional cDNA library screening. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Pr07  0.41
2012 Greenblatt MB, Vrbanac V, Vbranac V, Tivey T, Tsang K, Tager AM, Aliprantis AO. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. Plos One. 7: e44664. PMID 22957096 DOI: 10.1371/Journal.Pone.0044664  0.327
2012 Weigert O, Bodegom Dv, Bird L, Saur A, Tivey T, Kopp N, Kung AL, Weinstock D. Newer-Generation HSP90 Inhibitors Have Potent Activity Against Human Mantle Cell Lymphoma in Vitro and in Vivo Blood. 120: 1651-1651. DOI: 10.1182/Blood.V120.21.1651.1651  0.36
2012 Lane AA, van Bodegom D, Chapuy B, Alexe G, Sullivan TJ, Tivey T, Day T, Crispino J, Fox E, Stegmaier K, Weinstock D. Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets Blood. 120: 115-115. DOI: 10.1182/Blood.V120.21.115.115  0.458
Show low-probability matches.